King SY - Search Results

1

ELISA determination and preliminary pharmacokinetics of modified human rIL-1 beta in dogs.

Gray JE, Peterman V, Newton R, King SY, Pieniaszek HJ Jr. Gray JE, et al. Among authors: king sy. Res Commun Chem Pathol Pharmacol. 1993 Aug;81(2):233-41. Res Commun Chem Pathol Pharmacol. 1993. PMID: 8210701

2

Effects of multiple doses of moricizine hydrochloride on its pharmacokinetics and hepatic microsomal enzymes in rats.

King SY, Powel RJ, Wong YN, Davidson AF, Vincent DR, Quon CY, Pieniaszek HJ Jr. King SY, et al. Res Commun Chem Pathol Pharmacol. 1992 Mar;75(3):259-74. Res Commun Chem Pathol Pharmacol. 1992. PMID: 1509197

3

Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers.

Benedek IH, Joshi AS, Pieniaszek HJ, King SY, Kornhauser DM. Benedek IH, et al. Among authors: king sy. J Clin Pharmacol. 1995 Dec;35(12):1181-6. doi: 10.1002/j.1552-4604.1995.tb04044.x. J Clin Pharmacol. 1995. PMID: 8750369 Clinical Trial.

4

Dose-dependent pharmacokinetics of warfarin in healthy volunteers.

King SY, Joslin MA, Raudibaugh K, Pieniaszek HJ Jr, Benedek IH. King SY, et al. Pharm Res. 1995 Dec;12(12):1874-7. doi: 10.1023/a:1016223418652. Pharm Res. 1995. PMID: 8786959

5

Effect of moricizine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Benedek IH, King SY, Powell RJ, Agra AM, Schary WL, Pieniaszek HJ Jr. Benedek IH, et al. Among authors: king sy. J Clin Pharmacol. 1992 Jun;32(6):558-63. doi: 10.1177/009127009203200612. J Clin Pharmacol. 1992. PMID: 1634644

6

Protein binding of brequinar in the plasma of healthy donors and cancer patients and analysis of the relationship between protein binding and pharmacokinetics in cancer patients.

King SY, Agra AM, Shen HS, Chi CL, Adams DB, Currie VE, Bertino JR, Pieniaszek HJ Jr, Quon CY. King SY, et al. Cancer Chemother Pharmacol. 1994;35(2):101-8. doi: 10.1007/BF00686630. Cancer Chemother Pharmacol. 1994. PMID: 7987984 Clinical Trial.

7

Plasma protein binding of highly bound drugs: implications of radiochemical impurities.

Joshi AS, Pieniaszek HJ Jr, Quon CY, King SY. Joshi AS, et al. Among authors: king sy. J Pharm Sci. 1994 Aug;83(8):1187-8. doi: 10.1002/jps.2600830823. J Pharm Sci. 1994. PMID: 7983608 No abstract available.

8

Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipients.

Joshi AS, King SY, Zajac BA, Makowka L, Sher LS, Kahan BD, Menkis AH, Stiller CR, Schaefle B, Kornhauser DM. Joshi AS, et al. Among authors: king sy. J Clin Pharmacol. 1997 Dec;37(12):1121-8. doi: 10.1002/j.1552-4604.1997.tb04296.x. J Clin Pharmacol. 1997. PMID: 9506007 Clinical Trial.

9

Simultaneous quantification of an anti-inflammatory compound (DuP 697) and a potential metabolite (X6882) in human plasma and urine by high-performance liquid chromatography.

Joshi AS, Raghavan N, Williams RM, Takahashi K, Shingu H, King SY. Joshi AS, et al. Among authors: king sy. J Chromatogr B Biomed Appl. 1994 Oct 3;660(1):143-50. doi: 10.1016/0378-4347(94)00272-x. J Chromatogr B Biomed Appl. 1994. PMID: 7858707

10

Nanogram level quantitation of oxycodone in human plasma by capillary gas chromatography using nitrogen-phosphorus selective detection.

Kapil RP, Padovani PK, King SY, Lam GN. Kapil RP, et al. Among authors: king sy. J Chromatogr. 1992 Jun 10;577(2):283-7. doi: 10.1016/0378-4347(92)80249-p. J Chromatogr. 1992. PMID: 1400759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters